Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lothgren, Mickael
and
Ratcliffe, Mark
2004.
Pharmaceutical industry's perspective on health technology assessment.
International Journal of Technology Assessment in Health Care,
Vol. 20,
Issue. 1,
p.
97.
ten Have, Henk
2004.
Ethical perspectives on health technology assessment.
International Journal of Technology Assessment in Health Care,
Vol. 20,
Issue. 1,
p.
71.
Chantler, Cyril
2004.
Health-care technology assessment: a clinical perspective.
International Journal of Technology Assessment in Health Care,
Vol. 20,
Issue. 1,
p.
87.
Chinitz, David
2004.
Health technology assessment in four countries: response from political science.
International Journal of Technology Assessment in Health Care,
Vol. 20,
Issue. 1,
p.
55.
Beersen, Nicoline
Redekop, W. Ken
de Bruijn, J.H. Bart
Theuvenet, Peter J.
Berg, Marc
and
Klazinga, Niek S.
2005.
Quality based social insurance coverage and payment of the application of a high cost medical therapy: the case of spinal cord stimulation for chronic non-oncologic pain in The Netherlands.
Health Policy,
Vol. 71,
Issue. 1,
p.
107.
Theuvenet, Peter J.
Dekkers, Monique A.
Beersen, Nicoline
Klazinga, Niek S.
and
Spincemaille, Geert H.J.J.
2005.
The Development of a Quality System for Neuromodulation in the Netherlands.
Neuromodulation: Technology at the Neural Interface,
Vol. 8,
Issue. 1,
p.
28.
Gagnon, Marie-Pierre
Sánchez, Emília
and
Pons, Joan MV
2006.
From recommendation to action: psychosocial factors influencing physician intention to use Health Technology Assessment (HTA) recommendations.
Implementation Science,
Vol. 1,
Issue. 1,
Gerhardus, A.
2006.
Die Rolle von HTA-Berichten im deutschen Gesundheitswesen.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz,
Vol. 49,
Issue. 3,
p.
233.
Niessen, Louis W.
Grijseels, Els
Koopmanschap, Marc
and
Rutten, Frans
2007.
Economic analysis for clinical practice – the case of 31 national consensus guidelines in the Netherlands.
Journal of Evaluation in Clinical Practice,
Vol. 13,
Issue. 1,
p.
68.
de Bont, Antoinette
Zandwijken, Gladys
Stolk, Elly
and
Niessen, Louis
2007.
Prioritisation by physicians in the Netherlands—The growth hormone example in drug reimbursement decisions.
Health Policy,
Vol. 80,
Issue. 3,
p.
369.
Douma, Kirsten F. L.
Karsenberg, Kim
Hummel, Marjan J. M.
Bueno-de-Mesquita, Jolien M.
and
van Harten, Wim H.
2007.
Methodology of constructive technology assessment in health care.
International Journal of Technology Assessment in Health Care,
Vol. 23,
Issue. 2,
p.
162.
Lafortune, Louise
Farand, Lambert
Mondou, Isabelle
Sicotte, Claude
and
Battista, Renaldo
2008.
Assessing the performance of health technology assessment organizations: A framework.
International Journal of Technology Assessment in Health Care,
Vol. 24,
Issue. 01,
p.
76.
Lehoux, Pascale
Hivon, Myriam
Denis, Jean-Louis
and
Tailliez, Stéphanie
2008.
Health Technology Assessment in the Canadian Health Policy Arena.
Evaluation,
Vol. 14,
Issue. 3,
p.
295.
Gerhardus, Ansgar
and
Kathrin Stich, Anne
2008.
Sozio-kulturelle Aspekte in Health Technology Assessments (HTA).
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen,
Vol. 102,
Issue. 2,
p.
77.
Gerhardus, Ansgar
Lühmann, Dagmar
Velasco-Garrido, Marcial
Walter, Ulla
and
Razum, Oliver
2008.
Prävention und Versorgungsforschung.
p.
35.
Lehoux, Pascale
Daudelin, Genevieve
Demers-Payette, Olivier
and
Boivin, Antoine
2009.
Fostering deliberations about health innovation: What do we want to know from publics?.
Social Science & Medicine,
Vol. 68,
Issue. 11,
p.
2002.
Niezen, Maartje G. H.
de Bont, Antoinette
Busschbach, Jan J. V.
Cohen, Joshua P.
and
Stolk, Elly A.
2009.
Finding legitimacy for the role of budget impact in drug reimbursement decisions.
International Journal of Technology Assessment in Health Care,
Vol. 25,
Issue. 01,
p.
49.
Okma, Kieke G. H.
Cheng, Tsung-mei
Chinitz, David
Crivelli, Luca
Lim, Meng-kin
Maarse, Hans
and
Labra, Maria Eliana
2010.
Six Countries, Six Health Reform Models? Health Care Reform in Chile, Israel, Singapore, Switzerland, Taiwan and The Netherlands.
Journal of Comparative Policy Analysis: Research and Practice,
Vol. 12,
Issue. 1-2,
p.
75.
Menon, Devidas
and
Stafinski, Tania
2011.
Role of patient and public participation in health technology assessment and coverage decisions.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 11,
Issue. 1,
p.
75.
Valerio, L.
and
Ricciardi, W.
2011.
The current status of decision-making procedures and quality assurance in Europe: an overview.
Medicine, Health Care and Philosophy,
Vol. 14,
Issue. 4,
p.
383.